Dynamics of SERPINA3 in response to anthracycline treatment and cardiovascular dysfunction

Dynamics of SERPINA3 in response to anthracycline treatment and cardiovascular dysfunction

Abstract Background SERPINA3 recently emerged as potential prognostic biomarker in heart failure. In a population of cancer survivors with cancer therapy-related cardiac dysfunction (CTRCD) circulating SERPINA3 was elevated compared to age-matched controls. We aimed to assess the longitudinal dynami...

Full description

Saved in:
Bibliographic Details
Main Authors: Hanne M. Boen, Lobke L. Pype, Konstantinos Papadimitriou, Sevilay Altintas, Laure-Anne Teuwen, Sébastien Anguille, Kirsten Saevels, Anke Verlinden, Leen Delrue, Ward A. Heggermont, Matthias Bosman, Pieter-Jan Guns, Hein Heidbuchel, Caroline M. Van De Heyning, Emeline M. Van Craenenbroeck, Constantijn Franssen
Format: Article
Language:English
Published: BMC 2025-03-01
Series:Cardio-Oncology
Subjects:
Cancer therapy-related cardiac dysfunction (CTRCD)
SERPINA3
Cardiotoxicity
Biomarker
Anthracycline
Breast cancer
Online Access:https://doi.org/10.1186/s40959-025-00324-7
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items